Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 45802-107

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pseudoephedrine Hydrochloride (NDC 45802-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

054rt Pseudoephedrine Hydrochloride Image1

The packaging label for Perrigo Pseudoephedrine Hydrochloride Extended Release Tablets contains 10 coated caplets, each with 120 mg of active ingredient. It is labeled as a nasal decongestant for sinus pressure and congestion. The product is described as maximum strength, non-drowsy, and intended for 12-hour sinus relief. The caplets are capsule-shaped and the label includes the NDC 45802-107-52 and the Padagis Israel Pharmaceuticals Ltd labeler.*

FDA Label Image

054rt Pseudoephedrine Hydrochloride Image2

Drug Facts label for pseudoephedrine hydrochloride 120 mg extended-release film-coated tablets. Covers active ingredient, uses, warnings, directions for adults, children, and infants, other information, inactive ingredients, and distributor details. Includes dosage guidelines and safety precautions for use, storage, and handling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.